Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men

38Citations
Citations of this article
132Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Novel male-based contraceptives are needed to broaden family planning choices. A progestin, Nestorone® (Nes) gel, plus a testosterone (T) gel suppresses sperm concentrations to levels associated with effective contraception in normal men. However, administration of two gels on different parts of the body daily is impractical. Objective: Compare the effectiveness of daily application of a single, combined 8.3 mg Nes-62.5 mg T gel (Nes-T) vs. 62.7 mg T gel to suppress serum FSH and LH concentrations to ≤1.0 IU/L (a threshold associated with suppression of sperm concentrations to ≤1 million and effective contraception) and to compare the pharmacokinetics of serum Nes and T concentrations between the gel groups. Design: We conducted a 28-day, double-blind, controlled trial of 44 healthy men randomized to daily Nes-T or T gel with measurement of hormones at baseline, treatment, and recovery and during 24-h pharmacokinetic studies on days 1 and 28 of treatment. Results: Of the subjects who met pre-defined inclusion criteria, 84% of the Nes-T group suppressed serum gonadotropin concentrations to ≤1.0 IU/L at days 21–28 vs. 16.7% in the T group (p < 0.001). On day 1, Nes concentrations rose significantly above baseline by 2 h and continued to rise up to 24 h after Nes-T gel application. Nes concentrations were not detectable in the T group. Serum total T concentrations rose and were significantly higher in the T gel group compared to the Nes-T group at 24 h on day 1 and days 11, 14, and 21 (p < 0.01). There were no serious adverse events in either group. About 80% of the subjects reported satisfaction with both gels. Conclusion: Daily Nes-T gel effectively and safely suppresses serum gonadotropins and is acceptable to most men. It should be studied further in efficacy trials of hormonal male contraception.

References Powered by Scopus

The PHQ-9: Validity of a brief depression severity measure

31621Citations
N/AReaders
Get full text

A critical evaluation of simple methods for the estimation of free testosterone in serum

3332Citations
N/AReaders
Get full text

The American Urological Association symptom index for benign prostatic hyperplasia

3062Citations
N/AReaders
Get full text

Cited by Powered by Scopus

On-demand male contraception via acute inhibition of soluble adenylyl cyclase

46Citations
N/AReaders
Get full text

Progress in progestin-based therapies for neurological disorders

29Citations
N/AReaders
Get full text

Emerging approaches to male contraception

28Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Anawalt, B. D., Roth, M. Y., Ceponis, J., Surampudi, V., Amory, J. K., Swerdloff, R. S., … Wang, C. (2019). Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men. Andrology, 7(6), 878–887. https://doi.org/10.1111/andr.12603

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

63%

Researcher 6

25%

Lecturer / Post doc 2

8%

Professor / Associate Prof. 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

52%

Biochemistry, Genetics and Molecular Bi... 7

21%

Nursing and Health Professions 5

15%

Social Sciences 4

12%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 5
References: 2
Social Media
Shares, Likes & Comments: 6

Save time finding and organizing research with Mendeley

Sign up for free